Viral infection after renal transplantation: Surveillance and management

被引:97
作者
Weikert, Blair C. [1 ]
Blumberg, Emily A. [1 ]
机构
[1] Hosp Univ Penn, Div Infect Dis, Dept Med, Philadelphia, PA 19104 USA
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2008年 / 3卷
关键词
D O I
10.2215/CJN.02900707
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Viral infections remain a significant cause of morbidity and mortality following renal transplantation. Although cytomegalovirus is the most common opportunistic pathogen seen in transplant recipients, numerous other viruses have also affected outcomes. In some cases, preventive measures such as pretransplant screening, prophylactic antiviral therapy, or post transplant viral monitoring may limit the impact of these infections. Recent advances in laboratory monitoring and antiviral therapy have improved outcomes. This review will summarize the major viral infections seen following transplant and discuss strategies for prevention and management of these potential pathogens.
引用
收藏
页码:S76 / S86
页数:11
相关论文
共 106 条
[41]   Adenovirus infections in transplant recipients [J].
Ison, MG .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (03) :331-339
[42]   Transmission of West Nile virus from an organ donor to four transplant recipients [J].
Iwamoto, M ;
Jernigan, DB ;
Guasch, A ;
Trepka, MJ ;
Blackmore, CG ;
Hellinger, WC ;
Pham, SM ;
Zaki, S ;
Lanciotti, RS ;
Lance-Parker, SE ;
DiazGranados, CA ;
Winquist, AG ;
Perlino, CA ;
Wiersma, S ;
Hillyer, KL ;
Goodman, JL ;
Marfin, AA ;
Chamberland, ME ;
Petersen, LR ;
Blake, P ;
Bower, W ;
Dowdy, L ;
Fleming, J ;
Guarner, J ;
Jimenez, J ;
Kuehnert, M ;
Leguen, F ;
Luu, T ;
Mallon, S ;
Moseley, R ;
Nejman, A ;
Page, P ;
Pealer, L ;
Qi, XS ;
Rico, E ;
Roehrig, J ;
Rollin, P ;
Salameh, M ;
Shieh, WJ ;
Tso, P ;
Withum, D .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (22) :2196-2203
[43]   A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients [J].
John, GT ;
Manivannan, J ;
Chandy, S ;
Peter, S ;
Fleming, DH ;
Chandy, SJ ;
Balakrishnan, N ;
Krishnamurthy, K ;
Kirubakaran, MG ;
Jacob, CK .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (10) :4303-4305
[44]   Leflunomide therapy for cytomegalovirus disease in renal allograft recepients [J].
John, GT ;
Manivannan, J ;
Chandy, S ;
Peter, S ;
Jacob, CK .
TRANSPLANTATION, 2004, 77 (09) :1460-1461
[45]   Retransplantation after post-transplant lymphoproliferative disorders: An OPTN/UNOS database analysis [J].
Johnson, S. R. ;
Cherikh, W. S. ;
Kauffman, H. M. ;
Pavlakis, M. ;
Hanto, D. W. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (11) :2743-2749
[46]   Polyomavirus-associated nephropathy: update on antiviral strategies [J].
Josephson, M. A. ;
Williams, J. W. ;
Chandraker, A. ;
Randhawa, P. S. .
TRANSPLANT INFECTIOUS DISEASE, 2006, 8 (02) :95-101
[47]   Factors accelerating liver fibrosis progression in renal transplant patients receiving ribavirin monotherapy for chronic hepatitis C [J].
Kamar, N ;
Boulestin, A ;
Selves, J ;
Esposito, L ;
Sandres-Saune, K ;
Stébenet, M ;
Chatelut, E ;
Durand, D ;
Rostaing, L ;
Izopet, J .
JOURNAL OF MEDICAL VIROLOGY, 2005, 76 (01) :61-68
[48]   Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: Effects on renal function and liver histology [J].
Kamar, N ;
Sandres-Saune, K ;
Selves, J ;
Ribes, D ;
Cointault, O ;
Durand, D ;
Izopet, J ;
Rostaing, L .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (01) :184-192
[49]   The first case of JC virus allograft nephropathy [J].
Kazory, A ;
Ducloux, D ;
Chalopin, JM ;
Angonin, R ;
Fontanière, B ;
Moret, H .
TRANSPLANTATION, 2003, 76 (11) :1653-1655
[50]   Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients [J].
Khoury, J. A. ;
Storcha, G. A. ;
Bohl, D. L. ;
Schuessler, R. M. ;
Torrence, S. M. ;
Lockwood, M. ;
Gaudreault-Keener, M. ;
Koch, M. J. ;
Miller, B. W. ;
Hardinger, K. L. ;
Schnitzler, M. A. ;
Brennan, D. C. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (09) :2134-2143